Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Marks

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos Computational Biology|December 13, 2021
Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodiesSarah A Robinson, Matthew I J Raybould, Constantin Schneider, et al.
Nucleic Acids Research|September 27, 2019
Thera-SAbDab: the Therapeutic Structural Antibody DatabaseMatthew I J Raybould, Claire Marks, Alan P Lewis, et al.
Plos Computational Biology|February 19, 2020
Structural diversity of B-cell receptor repertoires along the B-cell differentiation axis in humans and miceAleksandr Kovaltsuk, Matthew I J Raybould, Wing Ki Wong, et al.
Nucleic Acids Research|May 1, 2016
SAbPred: a structure-based antibody prediction serverJames Dunbar, Konrad Krawczyk, Jinwoo Leem, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2019
Five computational developability guidelines for therapeutic antibody profilingMatthew I J Raybould, Claire Marks, Konrad Krawczyk, et al.
Global Spine Journal|April 1, 2025
Fusion versus Non-fusion Surgery for Pediatric Idiopathic Scoliosis: Preferences of Patients, Caregivers, and Patient-Caregiver DyadsVincent J Devlin, Juan Marcos Gonzalez Sepulveda, David Gebben, et al.
The Journal of Bone and Joint Surgery. American Volume|November 9, 2023
Non-Fusion Versus Fusion Surgery in Pediatric Idiopathic Scoliosis: What Trade-Offs in Outcomes Are Acceptable for the Patient and Family?A Noelle Larson, Michelle Claire Marks, Juan Marcos Gonzalez Sepulveda, et al.
Mabs|June 3, 2025
Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutationsFrédéric A Dreyer, Constantin Schneider, Aleksandr Kovaltsuk, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos Computational Biology|December 13, 2021
Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodiesSarah A Robinson, Matthew I J Raybould, Constantin Schneider, et al.
Nucleic Acids Research|September 27, 2019
Thera-SAbDab: the Therapeutic Structural Antibody DatabaseMatthew I J Raybould, Claire Marks, Alan P Lewis, et al.
Plos Computational Biology|February 19, 2020
Structural diversity of B-cell receptor repertoires along the B-cell differentiation axis in humans and miceAleksandr Kovaltsuk, Matthew I J Raybould, Wing Ki Wong, et al.
Nucleic Acids Research|May 1, 2016
SAbPred: a structure-based antibody prediction serverJames Dunbar, Konrad Krawczyk, Jinwoo Leem, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2019
Five computational developability guidelines for therapeutic antibody profilingMatthew I J Raybould, Claire Marks, Konrad Krawczyk, et al.
Global Spine Journal|April 1, 2025
Fusion versus Non-fusion Surgery for Pediatric Idiopathic Scoliosis: Preferences of Patients, Caregivers, and Patient-Caregiver DyadsVincent J Devlin, Juan Marcos Gonzalez Sepulveda, David Gebben, et al.
The Journal of Bone and Joint Surgery. American Volume|November 9, 2023
Non-Fusion Versus Fusion Surgery in Pediatric Idiopathic Scoliosis: What Trade-Offs in Outcomes Are Acceptable for the Patient and Family?A Noelle Larson, Michelle Claire Marks, Juan Marcos Gonzalez Sepulveda, et al.
Mabs|June 3, 2025
Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutationsFrédéric A Dreyer, Constantin Schneider, Aleksandr Kovaltsuk, et al.
Pageof 2